© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Dexibuprofen stands out as the pharmacologically active enantiomer of ibuprofen. Compared to standard ibuprofen, dexibuprofen offers analysts, pharmacists, and formulators improved efficiency, as it represents the S(+)-enantiomer. This molecular difference directly affects how the body processes and benefits from the drug, reducing the required dose for achieving targeted anti-inflammatory and analgesic effects. People in clinical settings value this feature because it can reduce the risk of gastrointestinal irritation often seen at higher dosages. Dexibuprofen appears as a white or almost white crystalline powder and has a faint, characteristic odor. It completes its dissolution in organic solvents more than water, which becomes evident in formulation work. Each batch delivers consistent results due to the purity and defined stereochemistry.
Dexibuprofen possesses the molecular formula C13H18O2 and a molar mass of 206.28 g/mol. The structure comprises a carboxylic acid group attached to a phenyl ring, with a methyl-propyl side chain defining its chiral center. These elements contribute to its physicochemical behavior in solid and dissolved states, such as solubility profiles, partition coefficients, and recrystallization characteristics. Its chiral nature means laboratories must employ precise analytical tools like chiral HPLC to verify enantiomeric purity. Dexibuprofen highlights how small structural shifts can influence therapeutic outcomes and manufacturing approaches.
The substance typically presents as a solid, white crystalline powder, not unlike many other non-steroidal anti-inflammatory drugs. Its density averages at 1.08 g/cm³, influencing storage, transportation, and formulation techniques. The melting point commonly ranges from 52°C to 54°C, so keeping ambient temperatures lower prevents clumping or melting. Dexibuprofen shows low water solubility; typical values hover around 21 mg/L at 25°C. It dissolves more freely in alcohol, acetone, and chloroform, facilitating processing during raw material integration or final dosage preparation. Powdered forms are most often utilized, as this supports efficient metering, blending, and tablet compaction in large-scale manufacturing. The crystalline structure aids in maintaining stability and shelf life.
Pharmaceutical producers offer dexibuprofen in diverse forms—flakes, powders, and solid granules—to suit a range of downstream applications. Flakes and powders support rapid dispersion within mixing tanks, while larger pearls or solid forms are ideal for controlled, gradual feed into automated equipment. Consistent particle size distribution can yield stable suspension and accurate dosing in the end product, which matters both for patient outcomes and regulatory compliance. The absence of liquid or solution formulations means most users engage with dexibuprofen as a dry active pharmaceutical ingredient. Choosing the right format means smoother integration into tailored delivery forms such as tablets, capsules, or topical preparations.
For customs, logistics, and trade, dexibuprofen carries the Harmonized System (HS) code 29163990. This code places it within the classification of aromatic carboxylic acids and their derivatives, reflecting its chemical lineage. Suppliers must provide certification of quality analysis, traceability for raw materials, and documentation for each shipment to avoid regulatory issues and support global distribution. Specifications typically cover parameters like assay purity (minimum 98.5%), moisture content (below 0.5%), specific optical rotation, and absence of residual solvents. Each parameter assures end users of product safety, efficacy, and regulatory alignment. Laboratories also watch for by-products and trace metals that originate during upstream synthesis or during handling.
Dexibuprofen, while a valuable pain reliever, requires careful attention during handling and transit. Classified as a non-hazardous material in its pure form, it nonetheless can cause irritation if dust inhalation or skin contact occurs in poorly ventilated settings. It is important to use gloves, dust masks, and eye safety protection when transferring or weighing the powder. Storage should remain cool, dry, and out of sunlight, preferably in tightly sealed containers to avoid moisture ingress. Although not considered acutely toxic, repeated unprotected exposure over long periods should be avoided. For industrial staff, facilities maintain safety data sheets (SDS) detailing permissible exposure limits, first aid steps, and fire-fighting procedures. As a raw material, accidental release or spillage protocols prioritize prompt, dry sweep collection and prevention of environmental contamination.
Within pharmaceuticals, dexibuprofen functions as a critical raw material used for anti-inflammatory and analgesic medications. Beyond tablets and capsules, some researchers explore new, targeted applications, including topical gels or controlled-release systems. Chemical manufacturers constantly monitor both the upstream synthesis methods—often seeking greener, waste-reducing alternatives—and downstream purification steps to enhance worker safety and minimize contaminants. At each stage, analytical verification assures both effectiveness and consistency. With the continuing search for better pain management options, the quality and reproducibility of dexibuprofen make it a pillar in medical chemistry circles.
